147 results
10-12G
EX-3.2
ATXI
Avenue Therapeutics Inc
12 Jan 17
Registration of securities
12:00am
may be called, at any time for any purpose or purposes, by the board of directors or by such person or persons as may be authorized by the certificate … at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called.
(b) Without limiting the manner by which
8-K
EX-3.1
ATXI
Avenue Therapeutics Inc
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
of the stockholders may be called, at any time for any purpose or purposes, by the board of directors or by such person or persons as may … in person and vote at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called.
(b) Without limiting
10-12G
EX-3.3
ATXI
Avenue Therapeutics Inc
30 Dec 15
Registration of securities
12:00am
may be called, at any time for any purpose or purposes, by the board of directors or by such person or persons as may be authorized by the certificate … at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called.
(b) Without limiting the manner by which
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
such purpose.
(b) Assurances. The Original Registration Statement, as amended, (and any further documents to be filed with the Commission) contains all … of interest with the Company. For this purpose, a “conflict of interest” exists when a Participating Member, the parent or affiliate of a Participating Member
10-12G
EX-3.1
ATXI
Avenue Therapeutics Inc
30 Dec 15
Registration of securities
12:00am
by each such holder, treating for this purpose all such shares of Class A Common Stock as if they had been converted to Common Stock pursuant to the terms … for that purpose or pursuant to a written consent of stockholders. At any meeting held for the purpose of electing a director, the presence in person or by proxy
10-12G/A
EX-10.8
a8jcu
18 Feb 16
Registration of securities (amended)
12:00am
10-12G
EX-3.1
lob01r gl7osde84l
12 Jan 17
Registration of securities
12:00am
8-K
EX-4.1
npnh islp7zsh51m8rz
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-4.3
e1g1xcm t2f8rq9
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-4.2
ue8cxf
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
EX-4.1
2fmjec2xy5d vslvlp8l
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
PRE 14C
215koqfp6qp668d0b2cm
17 Jan 24
Preliminary information
5:05pm
DEF 14C
84pttm23ibc60j
29 Jan 24
Information statement
8:00am
8-K
EX-10.1
wq5q9
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm